Top compounds associated with response to NOL4L


Feature Type Standardized
Nominal ANOVA
mRNA cimetidine CTRPv2 pan-cancer AAC 0.16 0.03
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.082 0.03
mRNA tigecycline CTRPv2 pan-cancer AAC -0.11 0.03
mRNA marinopyrrole A CTRPv2 pan-cancer AAC -0.1 0.03
mRNA IPA-3 GDSC1000 pan-cancer AAC -0.074 0.03
mRNA WZ-1-84 GDSC1000 pan-cancer AAC -0.11 0.03
mRNA CMK GDSC1000 pan-cancer AAC -0.12 0.03
mRNA piperlongumine GDSC1000 pan-cancer AAC -0.072 0.03
mRNA Salubrinal GDSC1000 pan-cancer AAC -0.11 0.03
mRNA SNS-032 CTRPv2 pan-cancer AAC -0.079 0.03
Download CSV